Shopify Inc. or Canopy Growth Corp.: Which Growth Stock Could Soar in 2018?

Shopify Inc. (TSX:SHOP)(NYSE:SHOP) and Canopy Growth Corp. (TSX:WEED) are both up more than 100% in the past 12 months. Is one preparing to repeat the performance?

Shopify Inc. (TSX: SHOP)(NYSE:SHOP) and Canopy Growth Corp. (TSX: WEED) have both gained more than 100% in the past 12 months.

Let’s take a look at the two Canadian market darlings to see if one might be a better pick heading into next year.

Shopify

Shopify’s steady rise to consistent new highs hit a speed bump recently when an influential short seller, Citron Research, released a negative report about the company’s marketing practices.

Citron claims marketing material on Shopify’s website is in violation of U.S. Federal Trade Commission rules and says the stock is significantly overvalued.

Shopify slipped from $145 per share to about $120 in the three days after the Citron report. The dip caused quite a stir among analysts and pundits, but it’s relatively insignificant considering the strong rally the stock has chalked up in 2017.

In fact, at the time of writing, Shopify is still up 113% on the year, trading at $123 per share.

A pullback was due, regardless of the reason, and while investors have to keep an eye on the situation in the near term to see how the market reacts to the Citron claims, Shopify’s longer-term outlook should be solid.

Why?

Shopify reported 75% year-over-year revenue growth for Q2 2017. If that trend continues, Citron’s criticisms could be quickly forgotten. Citron itself even says Shopify’s technology is “the best build-your-own e-commerce software on the market.”

In the near term, if Shopify makes another significant move to the downside, investors might want to consider adding a small position to their portfolios.

Canopy

Canopy is the market leader in the Canadian medical marijuana market, with more than 50,000 registered patients who purchase the company’s products through its online platform.

Canopy has made all the right moves in its efforts to cement itself as the dominant player in the growing medical marijuana market. The company has consolidated the industry through strategic acquisition, is forming important partnerships to ensure adequate production capacity and supply, and is expanding its global presence.

The stock trades at a valuation that is tough to justify based on the current revenue stream, but investors are looking beyond the medical marijuana market to the potential launch of a Canadian recreational market in mid-2018.

With estimates starting at close to $5 billion for the potential size of the recreational market in this country, the upside potential for Canopy is significant and the company could quickly grow into its $2 billion valuation.

The stock fell about 50% from the February closing high to the lows in early June amid concerns the opening of the market could be delayed.

Announcements by a handful of provinces regarding their plans to launch on time next year are bringing investors back into the sector, and Canopy is up 60% in the past three months as a result.

If more provinces start to declare plans to open their recreational marijuana businesses next year, the recent run in Canopy could extend much further.

Is one a better bet heading into 2018?

Both Shopify and Canopy are attractive growth picks in the Canadian market, and while volatility should be expected in the coming months, the long-term outlook for the two companies should be positive.

At this point, however, Canopy might offer more upside torque in the near term, especially if the company announces a flurry of supply agreements with the provinces through the end of 2017 into the first part of next year.

Shopify’s correction has been quite limited, given the scope of the Citron claims, so the stock could see more downside pressure before traders and the business media get bored and move on to the next story.

Fool contributor Andrew Walker has no position in any stock mentioned.Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Shopify and SHOPIFY INC. Shopify is a recommendation of Stock Advisor Canada.

More on Tech Stocks

dreaming of financial success
Dividend Stocks

Telus vs. Fortis: Which Stock Would I Choose for a More Dependable Payout?

Telus pays more today after its reset. I’d choose Fortis for the payout I’d rather count on over several years.

Read more »

Rocket lift off through the clouds
Tech Stocks

MDA Space Stock: Big Opportunities, but What Should Investors Pay?

MDA’s backlog gives investors work to follow. The share price asks how much of that work will turn into profit…

Read more »

investor looks at volatility chart
Dividend Stocks

2 Discounted TSX Dividend Stocks That Could Rebound in 2027

Two TSX dividend stocks currently trading at deep discounts are well-positioned to stage a strong rebound in 2027.

Read more »

AI image of a face with chips
Tech Stocks

OpenText’s AI Pitch Needs to Show Up in Earnings: Here’s What I’d Watch

At OpenText World, I heard how customers can move from searching their files to building AI agents. The earnings test…

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Tech Stocks

A Top Tech ETF for Canadians to Buy With $1,000

TD Global Technology Leaders Index ETF (TSX:TEC) stands out as a great ETF for Canadians looking to buy the correction…

Read more »

data center server racks glow with light
Energy Stocks

Hammond Power Stock: A Different Way to Invest in the Electricity Buildout

New power demand can mean more work for transformer makers. Hammond’s order book shows the opportunity, and its share price…

Read more »

AI concept person in profile
Tech Stocks

Shopify vs. CGI: Which Canadian Tech Stock Would I Add to a Retirement Portfolio?

Shopify’s growth is hard to ignore. I’d add CGI to a retirement portfolio first because I can put a more…

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

3 AI Stocks Canadians May Like Better Than Nvidia

Nvidia's stock is down 32% amid controversies. Discover the implications for Nvidia and the chip industry amid these concerns.

Read more »